The device is meant for skeletally mature patients who have had six months of non-operative treatment. It can be used at one level or two contiguous levels for degenerative disc disease with up to Grade I spondylolisthesis.
The implants can also be used to replace a vertebral body that has been resected or excised due to tumor or trauma fracture.
Read the DiFUSE release on the Xiphos line.
Read other coverage on spine devices:
– Medtronic Launches KYPHON Express Curette
– K2M Launches Lateral Access Spinal System
– Integra LifeSciences Receives FDA Clearance for ALIF Device
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
